Sänger Florian, Dörfelt Stefanie, Giani Bettina, Buhmann Gesine, Fischer Andrea, Dörfelt René
LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
AniCura Veterinary Hospital Haar, 85540 Haar, Germany.
Animals (Basel). 2023 Dec 21;14(1):33. doi: 10.3390/ani14010033.
A one-year-old, female intact Samoyed, 12.5 kg, was presented with coughing for 2 weeks, progressive appendicular and axial muscle weakness, megaesophagus and labored breathing for 5 days. There was no improvement with standard treatment. Acquired myasthenia gravis was suspected and the dog was referred with increasing dyspnea. At presentation, the dog showed a severely reduced general condition, was non-ambulatory and showed abdominal and severely labored breathing. A marked hypercapnia (PvCO = 90.1 mmHg) was present in venous blood gas analysis. The serum anti-acetylcholine receptor antibody test was consistent with acquired myasthenia gravis (2.1 nmol/L). The dog was anesthetized with propofol and mechanically ventilated with a Hamilton C1 ventilator. Immunoadsorption was performed with the COM.TEC and ADAsorb platforms and a LIGASORB adsorber to eliminate anti-acetylcholine receptor antibodies. Local anticoagulation was performed with citrate. Treatment time for immunoadsorption was 1.5 h with a blood flow of 50 mL/min. A total plasma volume of 1.2 L was processed. Further medical treatment included intravenous fluid therapy, maropitant, esomeprazole, antibiotic therapy for aspiration pneumonia and neostigmine 0.04 mg/kg intramuscularly every 6 h for treatment of acquired myasthenia gravis. Mechanical ventilation was stopped after 12 h. A percutaneous gastric feeding tube was inserted under endoscopic control on day 2 for further medical treatment and nutrition. A second treatment with immunoadsorption was performed on day 3. Again, a total plasma volume of 1.2 L was processed. Immediately after this procedure, the dog regained muscle strength and was able to stand and to walk. After 6 days, the dog was discharged from the hospital. This is the first report of immunoadsorption for emergency management of a dog with acute-fulminant acquired myasthenia gravis. Immunoadsorption may be an additional option for emergency treatment in dogs with severe signs of acquired myasthenia gravis.
一只12.5千克的一岁雌性未绝育萨摩耶犬,出现咳嗽2周,进行性四肢和躯干肌肉无力、巨食管以及呼吸困难5天。标准治疗后无改善。怀疑患有获得性重症肌无力,该犬因呼吸困难加重而转诊。就诊时,该犬全身状况严重下降,无法行走,出现腹部呼吸且呼吸极度费力。静脉血气分析显示明显的高碳酸血症(静脉血二氧化碳分压 = 90.1 mmHg)。血清抗乙酰胆碱受体抗体检测结果与获得性重症肌无力相符(2.1 nmol/L)。用丙泊酚对该犬进行麻醉,并使用Hamilton C1呼吸机进行机械通气。使用COM.TEC和ADAsorb平台以及LIGASORB吸附器进行免疫吸附,以清除抗乙酰胆碱受体抗体。用枸橼酸盐进行局部抗凝。免疫吸附治疗时间为1.5小时,血流速度为50毫升/分钟。共处理血浆总量1.2升。进一步的药物治疗包括静脉输液治疗、马罗匹坦、埃索美拉唑、针对吸入性肺炎的抗生素治疗以及每6小时肌肉注射0.04毫克/千克新斯的明以治疗获得性重症肌无力。12小时后停止机械通气。在第2天,在内镜引导下插入经皮胃饲管,用于进一步的药物治疗和营养支持。在第3天进行了第二次免疫吸附治疗。同样,共处理血浆总量1.2升。在此操作后,该犬立即恢复了肌肉力量,能够站立和行走。6天后,该犬出院。这是关于免疫吸附用于急性暴发性获得性重症肌无力犬紧急治疗的首例报告。免疫吸附可能是患有严重获得性重症肌无力体征犬紧急治疗的另一种选择。